Escherichia coli Nissle is a Gram-negative strain with many prominent probiotic properties in the treatment of intestinal diseases such as diarrhea and inflammatory bowel disease (IBD), in particular ulcerative colitis.
Escherichia coli Nissle not only exhibits antagonistic effects on a variety of intestinal pathogenic bacteria, but also regulates the secretion of immune factors in vivo and enhances the ability of host immunity.
References:
Ulcerative colitis—Maintanance of Remission With the Probiotic Escherichia coli Strain Nissle 1917 Eduard F. Stange, Rudolf von Bünau, Andreas Erhardt, Published:December 29, 2020, DOI:https://doi.org/10.1053/j.gastro.2020.12.040
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.